FDA approved anti-inflammatory drug shows promise for treating alcohol use disorder and pain
A preclinical study from scientists at Scripps Research finds that a drug already FDA-approved for treating inflammatory conditions may help...
How brokers can tame tariff impacts
How brokers can tame tariff impacts Opens in a new window Opens an external site Opens an external site...
Kevin Farrell: The organizer of the conclusion
FAZ+Cardinal Kevin Farrell : Event manager for the conclave04/22/2025, 21:05Reading time: 3 Min.Fold out the image descriptionSad message: Cardinal Kevin...
Dr. Jeremie Poschmann's data-driven approach to immunology and translational science
In a wide-ranging Genomic Press Interview, Dr. Jeremie Poschmann of INSERM and Université de Nantes shares the story behind his...
Trump Media embarks on the Crypto ETF with Crypto.com and Yorkville
Founded by Donald Trump, Trump Media & Technology Group accelerates his diversification in finance. The group launches negotiated stocks (ETF)...
Bittensor (TAO) explodes by +38 % in a week: how to explain this increase?
While Bitcoin seems to start up on Tuesday, April 22, and in full effervescence of cryptocurrencies focused on artificial intelligence,...
Parent column “sleepless”: “You are too stupid to hold the screw”
FAZ+Parent column "sleepless" : "You are too stupid to hold the screw"04/22/2025, 16:50Reading time: 6 Min.Fold out the image descriptionInstead...
The DOJ’s NCET Disbanded: What the “Blanche Memo” Means for Digital Assets
TL;DR: The DOJ’s new guidance emphasizes targeting criminal activity that exploits digital assets — not the regulatory status of the...
ClaimsPro Welcomes New Director of Marine Services
ClaimsPro Welcomes New Director of Marine Services Opens in a new window Opens an external site Opens an external...
Owlstone Medical announces investment of up to $2.3 million USD from the Cystic Fibrosis Foundation to develop a breath test for Pseudomonas aeruginosa detection in cystic fibrosis patients
Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced...